List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 4 Global active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 5 Global active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 6 Global active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 7 Global active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 8 Global active pharmaceutical ingredient CDMO market, by region, 2018 - 2030 (USD Million)
Table 9 North America active pharmaceutical ingredient CDMO market, by country, 2018 - 2030 (USD Million)
Table 10 North America active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 11 North America active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 12 North America active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 13 North America active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 14 North America active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 15 U.S. active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 16 U.S. active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 17 U.S. active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 18 U.S. active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 19 U.S. active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 20 Canada active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 21 Canada active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 22 Canada active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 23 Canada active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 24 Canada active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 25 Europe active pharmaceutical ingredient CDMO market, by country, 2018 - 2030 (USD Million)
Table 26 Europe active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 27 Europe active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 28 Europe active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 29 Europe active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 30 Europe active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 31 Germany active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 32 Germany active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 33 Germany active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 34 Germany active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 35 Germany active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 36 UK active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 37 UK active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 38 UK active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 39 UK active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 40 UK active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 41 France active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 42 France active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 43 France active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 44 France active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 45 France active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 46 Italy active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 47 Italy active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 48 Italy active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 49 Italy active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 50 Italy active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 51 Spain active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 52 Spain active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 53 Spain active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 54 Spain active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 55 Spain active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 56 Denmark active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 57 Denmark active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 58 Denmark active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 59 Denmark active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 60 Denmark active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 61 Sweden active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 62 Sweden active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 63 Sweden active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 64 Sweden active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 65 Sweden active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 66 Norway active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 67 Norway active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 68 Norway active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 69 Norway active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 70 Norway active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 71 Asia Pacific active pharmaceutical ingredient CDMO market, by country, 2018 - 2030 (USD Million)
Table 72 Asia Pacific active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 73 Asia Pacific active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 74 Asia Pacific active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 75 Asia Pacific active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 76 Asia Pacific active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 77 Japan active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 78 Japan active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 79 Japan active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 80 Japan active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 81 Japan active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 82 China active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 83 China active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 84 China active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 85 China active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 86 China active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 87 India active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 88 India active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 89 India active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 90 India active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 91 India active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 92 Australia active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 93 Australia active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 94 Australia active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 95 Australia active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 96 Australia active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 97 South Korea active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 98 South Korea active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 99 South Korea active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 100 South Korea active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 101 South Korea active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 102 Thailand active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 103 Thailand active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 104 Thailand active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 105 Thailand active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 106 Thailand active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million
Table 107 Latin America active pharmaceutical ingredient CDMO market, by country, 2018 - 2030 (USD Million)
Table 108 Latin America active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 109 Latin America active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 110 Latin America active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 111 Latin America active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 112 Latin America active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 113 Brazil active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 114 Brazil active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 115 Brazil active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 116 Brazil active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 117 Brazil active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 118 Mexico active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 119 Mexico active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 120 Mexico active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 121 Mexico active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 122 Mexico active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 123 Argentina active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 124 Argentina active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 125 Argentina active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 126 Argentina active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 127 Argentina active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 128 Colombia active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 129 Colombia active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 130 Colombia active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 131 Colombia active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 132 Colombia active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 133 Chile active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 134 Chile active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 135 Chile active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 136 Chile active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 137 Chile active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 138 Middle East & Africa active pharmaceutical ingredient CDMO market, by country, 2018 - 2030 (USD Million)
Table 139 Middle East & Africa active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 140 Middle East & Africa active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 141 Middle East & Africa active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 142 Middle East & Africa active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 143 Middle East & Africa active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 144 South Africa active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 145 South Africa active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 146 South Africa active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 147 South Africa active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 148 South Africa active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 149 Saudi Arabia active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 150 Saudi Arabia active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 151 Saudi Arabia active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 152 Saudi Arabia active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 153 Saudi Arabia active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 154 UAE active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 155 UAE active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 156 UAE active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 157 UAE active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 158 UAE active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
Table 159 Kuwait active pharmaceutical ingredient CDMO market, by product, 2018 - 2030 (USD Million)
Table 160 Kuwait active pharmaceutical ingredient CDMO market, by synthesis, 2018 - 2030 (USD Million)
Table 161 Kuwait active pharmaceutical ingredient CDMO market, by drug, 2018 - 2030 (USD Million)
Table 162 Kuwait active pharmaceutical ingredient CDMO market, by application, 2018 - 2030 (USD Million)
Table 163 Kuwait active pharmaceutical ingredient CDMO market, by workflow, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Active Pharmaceutical Ingredients CDMO market snapshot (2020)
Fig. 8 Active Pharmaceutical Ingredients CDMO market segmentation
Fig. 9 Parent market outlook
Fig. 10 Penetration & growth prospect mapping
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 FDA approval and biosimilar product launch trends from 2015 to 2020.
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Porter’s Five Forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Active Pharmaceutical Ingredients CDMO market Product outlook: Segment dashboard
Fig. 17 Active Pharmaceutical Ingredients CDMO market: Product movement analysis
Fig. 18 Traditional API market, 2018 - 2030 (USD Million)
Fig. 19 HP-API market, 2018 - 2030 (USD Million)
Fig. 20 Antibody-drug conjugate market, 2018 - 2030 (USD Million)
Fig. 21 Others market, 2018 - 2030 (USD Million)
Fig. 22 Active Pharmaceutical ingredients CDMO market synthesis outlook: segment dashboard
Fig. 23 Active pharmaceutical ingredients CDMO market: synthesis movement analysis
Fig. 24 Synthetic market, 2018 - 2030 (USD Million)
Fig. 25 Biotech market, 2018 - 2030 (USD Million)
Fig. 26 Active pharmaceutical ingredients CDMO market drug outlook: segment dashboard
Fig. 27 Active pharmaceutical ingredients CDMO market: drug movement analysis
Fig. 28 Innovative market, 2018 - 2030 (USD Million)
Fig. 29 Generics market, 2018 - 2030 (USD Million)
Fig. 30 Active pharmaceutical ingredients CDMO market application outlook: segment dashboard
Fig. 31 Active pharmaceutical ingredients CDMO market: application movement analysis
Fig. 32 Oncology market, 2018 - 2030 (USD Million)
Fig. 33 Hormonal market, 2018 - 2030 (USD Million)
Fig. 34 Glaucoma market, 2018 - 2030 (USD Million)
Fig. 35 Cardiovascular disease market, 2018 - 2030 (USD Million)
Fig. 36 Diabetes market, 2018 - 2030 (USD Million)
Fig. 37 Others market, 2018 - 2030 (USD Million)
Fig. 38 Active pharmaceutical ingredients CDMO market workflow outlook: segment dashboard
Fig. 39 Active pharmaceutical ingredients CDMO market: workflow movement analysis
Fig. 40 Clinical market, 2018 - 2030 (USD Million)
Fig. 41 Commercial market, 2018 - 2030 (USD Million)
Fig. 42 Regional market: Key takeaways
Fig. 43 Active Pharmaceutical Ingredients CDMO market: Regional movement analysis
Fig. 44 North America market, 2018 - 2030 (USD Million)
Fig. 45 U.S. market, 2018 - 2030 (USD Million)
Fig. 46 Canada market, 2018 - 2030 (USD Million)
Fig. 47 Europe market, 2018 - 2030 (USD Million)
Fig. 48 UK market, 2018 - 2030 (USD Million)
Fig. 49 Germany market, 2018 - 2030 (USD Million)
Fig. 50 France market, 2018 - 2030 (USD Million)
Fig. 51 Italy market, 2018 - 2030 (USD Million)
Fig. 52 Spain market, 2018 - 2030 (USD Million)
Fig. 53 Denmark market, 2018 - 2030 (USD Million)
Fig. 54 Sweden market, 2018 - 2030 (USD Million)
Fig. 55 Norway market, 2018 - 2030 (USD Million)
Fig. 56 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 57 India market, 2018 - 2030 (USD Million)
Fig. 58 Japan market, 2018 - 2030 (USD Million)
Fig. 59 China market, 2018 - 2030 (USD Million)
Fig. 60 Australia market, 2018 - 2030 (USD Million)
Fig. 61 South Korea market, 2018 - 2030 (USD Million)
Fig. 62 Thailand market, 2018 - 2030 (USD Million)
Fig. 63 Latin America market, 2018 - 2030 (USD Million)
Fig. 64 Brazil market, 2018 - 2030 (USD Million)
Fig. 65 Mexico market, 2018 - 2030 (USD Million)
Fig. 66 Argentina market, 2018 - 2030 (USD Million)
Fig. 67 Colombia market, 2018 - 2030 (USD Million)
Fig. 68 Chile market, 2018 - 2030 (USD Million)
Fig. 69 MEA market, 2018 - 2030 (USD Million)
Fig. 70 South Africa market, 2018 - 2030 (USD Million)
Fig. 71 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 72 UAE market, 2018 - 2030 (USD Million)
Fig. 73 Kuwait market, 2018 - 2030 (USD Million)